If a person has a prescription for a brand-name drug that is on a higher tier than its generic version, they can file an exception and ask the plan provider to review the drug options. Formulary ...

Opposition politicians had claimed the changes amounted to a "two-tier justice" system. Lord Justice William Davis, the chairman of the council, said that Mahmood's officials were fully briefed on ...

According to the Formulary Update released in February, Journavx has been placed on Tier 3 of Optum Rx Premium and Select Formularies and is being further evaluated by the Optum Rx National ...

Mask exception forms are now available for students at Tamaqua Area School District. That’s in response to the motion passed at last Tuesday’s Tamaqua Area School Board meeting to comply with the Wolf ...

Academic Student Exception Forms have been updated and are now available in Docusign. There are now 4 forms, Student Exception (chair/coordinator initiated), Student Exception (department initiated), ...

The trajectory of short-form video (SFV) content has been nothing ... brands to prioritise SFV lies in its unprecedented reach in tier-2 cities and beyond, which account for over 63% of total ...

SINGAPORE (The Straits Times/ANN): Advertisements for prescription-only medications for weight loss and other treatments are not allowed in all forms of media, the Singapore health authorities ...

All voters will be asked to show an ID before voting. If you do not have an ID, you may fill out an ID exception form and then vote with a provisional ballot. You can also vote with a provisional ...

This engagement represents an ongoing expansion of investment by a top-tier ... prescription platforms, competition, and other risks summarized in the Company’s Annual Report on Form 10-K ...

Rydapt (midostaurin) is a brand-name drug that’s prescribed for certain types of leukemia and mastocytosis in adults. Rydapt comes as an oral capsule that’s typically taken twice per day ...

I hope that everyone's 2024 has gotten off to a good start and I am excited to share several updates from the Office of Research and Innovation (ORI) to kick things off in this Spring 2024 newsletter.